Pathology Trivia Question Bank 

Hematopathology   Author: Sepi   Submit Date: 12/11/2006   Question: Describe an immunophenotypic way to differentiate Down’s syndrome patients with AML versus patient's with transient myeloproliferative disorder ?   Answer: AML in Down’s syndrome is usually CD13+, CD11b+ (positive). However the immunophenotypic profile in transient myeloproliferative disorder is usually CD13-, CD11b- (negative), AJCP 2001;116:204)         Views: 125   Votes: 0   Remote: 65.60.164.116                  A password is required for this operation:       Password: